Literature DB >> 9452248

Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty. Report of six cases.

L Stewart1, P Steinbok, J Daaboul.   

Abstract

Hypothalamic hamartomas (HHs) are benign tumors that are often associated with central precocious puberty. Resection of HHs has been recommended as a treatment option for selected cases of pedunculated lesions, especially in young children. The role of surgery has to be evaluated in the light of the availability of effective medical treatment with gonadotropin-releasing hormone analogs (GnRHas). The authors report the long-term results of total resection of HHs in two children with central precocious puberty and compare it with medical management in four children. The two surgically treated patients underwent total resection of pedunculated HHs at 1.75 (Case 1) and 3.25 years (Case 2) and have received follow-up care for 9 and 8 years, respectively. There were no postoperative complications and computerized tomography scanning confirmed complete tumor removal in both patients. Both patients subsequently experienced some regression of secondary sexual characteristics. The response of luteinizing hormone to GnRH became prepubertal in one patient and was diminished in the other. However, the growth velocity remained elevated (> 7 cm/year), bone age remained advanced (> +2 standard deviations) 5 years after surgery, decreasing adult height prediction. In one child, GnRHa therapy was initiated 7 years postsurgery. Four children were treated solely with GnRH agonists and have received follow-up care for 2.3, 6, 9, and 9 years, respectively. These patients have had a complete regression of endocrinological abnormalities, including a normalization of growth velocity and reduction in the rate of skeletal maturation. No side effects were noted with decapeptyl treatment, and one child developed sterile abscesses while receiving Lupron-Depot. The proven efficacy of GnRHa in suppressing puberty and reducing bone age advancement leads the authors to advise against surgery as the initial management of central precocious puberty caused by HHs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452248     DOI: 10.3171/jns.1998.88.2.0340

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

Review 1.  Recent advances in the diagnosis and treatment of precocious puberty.

Authors:  A Diaz; M Danon
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

Review 2.  Epilepsy related to hypothalamic hamartomas: surgical management with special reference to gamma knife surgery.

Authors:  Jean Régis; Didier Scavarda; Manabu Tamura; Mariko Nagayi; Nathalie Villeneuve; Fabrice Bartolomei; Thierry Brue; David Dafonseca; Patrick Chauvel
Journal:  Childs Nerv Syst       Date:  2006-06-29       Impact factor: 1.475

Review 3.  Is surgery effective for treating hypothalamic hamartoma causing isolated central precocious puberty? A systematic review.

Authors:  Mohit Agrawal; Raghu Samala; Ramesh Sharanappa Doddamani; Alpesh Goyal; Manjari Tripathi; Poodipedi Sarat Chandra
Journal:  Neurosurg Rev       Date:  2021-02-28       Impact factor: 3.042

4.  Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot.

Authors:  V N de Brito; A C Latronico; I J Arnhold; L S Lo; S Domenice; M C Albano; M C Fragoso; B B Mendonca
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

Review 5.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Surgical excision of hypothalamic hamartoma in a twenty months old boy with precocious puberty.

Authors:  Rajesh K Ghanta; Kalyan Koti; Srikanth Kongara; Gautham E Meher
Journal:  Indian J Endocrinol Metab       Date:  2011-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.